Évaluation du risque de maladie thromboembolique veineuse et de sa prévention chez des patients hospitalisés à Brazzaville

Geerts, 2008, Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 381, 10.1378/chest.08-0656 Fanikos, 2009, Long-term complications of medical patients with hospital-acquired venous thromboembolism, Thromb Haemost, 102, 688, 10.1160/TH09-04-0266 Piazza, 2009, Venous thromboembolic events in hospitalized medical patients, Thromb Haemost, 102, 505, 10.1160/TH09-03-0150 Konin, 2004, Les thromboses veineuses profondes des membres inférieurs en milieu tropical : aspects épidémiologiques et facteurs étiologiques, Med Afr Noire, 51, 469 Houénassi, 2005, Présentation clinique et étiologique de la thrombose veineuse des membres pelviens en cardiologie au CHNU de Cotonou, Le Bénin Médical, 30, 12 Sotunmbi, 2006, Prevalence of venous trhomboembolism at post-mortem in an African population: a cause for concern, Afr J Med Sci, 35, 345 Diall, 2011, Étiologie, clinique et évolution de l’embolie pulmonaire à propos de 30 cas, Mali Médical, 26, 3 Ondze-Kafata, 2012, La thrombose veineuse profonde des membres inférieurs à Brazzaville : à propos de 44 cas, Cardiol Trop, 135, 12 Deheinzelin, 2006, Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectionnal study, J Thrombo Heamost, 4, 1266, 10.1111/j.1538-7836.2006.01981.x Kahn, 2007, Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely all medical patients in Canada, Thrombo Res, 119, 145, 10.1016/j.thromres.2006.01.011 Cohen, 2008, Venous thromboembolism risk and prophylaxis in the acute hospital care settings (ENDORSE study): a multinational cross-sectional study, Lancet, 371, 387, 10.1016/S0140-6736(08)60202-0 Musial, 2008, Venous thromboembolism risk and prophylaxis in the acute hospital care settings: results of the ENDORSE study in Poland, Pol Arch Med Wewn, 118, 555 Nieto Rodriguez, 2009, Venous thromboembolism risk and antithrombotic prophylaxis among patients admitted to Spanish hospitals (ENDORSE study), Med Clin (Barc), 133, 1 Losonczy, 2010, Results of ENDORSE-2-Hungaria study. Repeated assessment of the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting, Orv Hetil, 151, 843, 10.1556/OH.2010.28895 Bergmann, 2010, Venous thromboembolism risk and prophylaxis in hospitalized medically ill patients: the ENDORSE Global survey, Thromb Haemost, 103, 736, 10.1160/TH09-09-0667 Kakkar, 2010, Venous thromboembolism risk and prophylaxis in the acute care hospital settings (ENDORSE survey): findings in surgical patients, Ann Surg, 251, 330, 10.1097/SLA.0b013e3181c0e58f Bergmann, 2011, Risque thromboembolique veineux et pratique de prévention hospitalière : résultats obtenus en France de l’étude internationale ENDORSE, Presse Med, 40, 528, 10.1016/j.lpm.2011.06.023 Jerbi, 2011, Risque et prévention de la maladie thromboembolique veineuse chez les malades hospitalisés : résultats tunisiens de l’étude ENDORSE, Tunis Med, 89, 784 Ba, 2011, A cross-sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal, Arch Cardiovasc Dis, 104, 493, 10.1016/j.acvd.2011.05.007 Goubran, 2012, Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt, Thromb J, 10, 20, 10.1186/1477-9560-10-20 Cohen, 2007, Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality, Thromb Haemost, 98, 756, 10.1160/TH07-03-0212 Kingué, 2014, Epidemiological African day for evaluation of patients at risk of venous thrombosis in acute hospital care settings, Cardiovasc J Afr, 25, 159, 10.5830/CVJA-2014-025 Geerts, 2004, Prevention of venous thromboembolism: the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 338S, 10.1378/chest.126.3_suppl.338S Cardiovascular Disease Educational and Research Trust, 2006, Prevention and treatment of venous thromboembolism. International Consensus Statement (Guidelines according to scientific evidence), Int Angiol, 25, 101 Cohen, 2005, Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients, Thromb Haemost, 94, 750, 10.1160/TH05-06-0385 Boukinda, 1996, La thrombophlébite profonde des membres inférieurs : une curiosité clinique en Afrique noire. Notre expérience à Brazzaville, Med Afr Noire, 2, 63 Houénassi, 2009, Prevention of venous thromboembolism among inpatients at Cotonou teaching hospital, Benin, Arch Cardiovasc Dis, 102, 5, 10.1016/j.acvd.2008.10.009 Malek, 2011, Venous thromboembolic disease in the HIV-infected patient, Am J Emerg Med, 29, 278, 10.1016/j.ajem.2009.09.034 Dentan, 2014, Active tuberculosis and venous thromboembolism: association according to international classification of diseases, ninth revision hospital discharge diagnosis codes, Clin Infect Dis, 58, 495, 10.1093/cid/cit780 Mismetti, 2000, Prevention of venous thromboembolism in internal medicine with unfractionated or low molecular weight heparins: a meta-analysis of randomised clinical trials, Thromb Haemost, 83, 14, 10.1055/s-0037-1613749 Leroyer, 2015, J Mal Vasc, 40, 248, 10.1016/j.jmv.2015.05.001 Albaladejo, 2014, Bon usage d’apixaban : que retenir pour la pratique, J Mal Vasc, 39, 409, 10.1016/j.jmv.2014.09.002 Ferrières, 2013, Aspirine et prévention de la maladie veineuse thromboembolique : la suite d’une belle histoire, J Mal Vasc, 38, 4, 10.1016/j.jmv.2012.12.001